Related Experiment Video
Updated: Feb 23, 2026

05:23
Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
20.5K
From anemia to polycythemia in 4 weeks
Omer A Hassan1,2, Melissa Y Y Moey1,3, Christos N Papageorgiou4,5
1Saba University School of Medicine The Bottom Saba Dutch Caribbean The Netherlands.
Clinical Case Reports
|September 8, 2017
Summary
Primary polycythemia (PCV) can occur with Thrombotic thrombocytopenic purpura (TTP). Investigating autoimmune conditions like rheumatoid arthritis (RA) is crucial for diagnosing TTP in certain patients.
Area of Science:
- Hematology
- Immunology
- Internal Medicine
Background:
- Primary polycythemia (PCV) is a condition that can be asymptomatic.
- Thrombotic thrombocytopenic purpura (TTP) is a rare blood disorder.
- Autoimmune conditions may present alongside or cause other hematological disorders.
Observation:
- Asymptomatic patients may present with coexisting Primary polycythemia (PCV) and Thrombotic thrombocytopenic purpura (TTP).
- Autoimmune conditions, specifically rheumatoid arthritis (RA), should be considered in cases of presumed "idiopathic TTP."
Findings:
- Rheumatoid arthritis (RA) can be an underlying cause of TTP in certain patient populations.
- Early identification of autoimmune etiologies is essential for appropriate TTP management.
Implications:
- Investigating autoimmune conditions is recommended for patients with unexplained TTP.
- Standardization of targeted immunomodulatory therapies may improve outcomes for patients with TTP secondary to autoimmune diseases.
- This highlights the importance of a comprehensive diagnostic approach in complex hematological disorders.
Keywords:
Anemiaautoimmune diseasepolycythemia verarheumatoid arthritisthrombotic thrombocytopenic purpuraMore Related Videos
Related Concept Videos
Disorders of Erythrocytes
2.4K
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
2.4K
Erythropoiesis
6.2K
Red blood cells (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia,...
6.2K
Factors Affecting Erythropoiesis
6.3K
The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
6.3K
Lifecycle of Erythrocytes
5.5K
Erythrocytes, also known as red blood cells, constantly move through blood capillaries. As a result, they damage their plasma membrane due to the continuous friction. Typically, after 100 to 120 days, erythrocytes become rigid and fragile as they wear out. As they pass through small vessels in the spleen and liver, they can get trapped and break apart into fragments.
The resident phagocytic macrophages deal with these damaged cells by engulfing them and separating their globin and heme groups....
The resident phagocytic macrophages deal with these damaged cells by engulfing them and separating their globin and heme groups....
5.5K
Overview of Hematopoiesis
10.3K
Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
10.3K
Hematopoiesis
9.3K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
9.3K

